View All Attorneys

Attorneys

William N. Wofford

William N. Wofford

William N. Wofford

Bill leads the biopharmaceutical and life sciences practice at Hutchison. His practice focuses on structuring and negotiating transactions for drug development, biotechnology, medical device and healthcare services companies. Bill assists growing and established companies raise capital, acquire and out-license technology, collaborate with strategic partners and engage in mergers and acquisitions. Since 1997, he has served the Research Triangle's entrepreneurial community. 

Recognition, Affiliations & Memberships

  • Co-author and Editor, Biotechnology and the Law (American Bar Association, 2007)
  • Board of Directors, SEBIO, 2009
  • Member, Entrepreneurial Council for the Wake Forest University Translational Science Institute (TSI)
  • Best Lawyers in America, recognized annually since 2007
  • Member, Licensing Executives Society
  • Member, American Bar Association’s Business Section and Science and Technology Committee
  • Member, North Carolina Bioscience Industry Organization
  • Super Lawyers, 2006, 2008
  • Former Vice Chairman, Board of Directors, Gainesville Area Innovation Network (GAIN)
  • Former Editor, Food & Drug Law Journal, Food & Drug Law Institute (FDLI)
  • Former Chair & Vice Chair, Austern Writing Awards Committee, Long Papers, FDLI
  • Member, BioFlorida

Education

  • J.D., University of Virginia, 1994
  • B.A., University of Virginia, 1989

 Admissions

  • New York
  • North Carolina

Select Publications & Presentations

  • Pharmaceutical Licensing Agreements, NC State University Poole College of Management
  • Legal Issues Related to Clinical Research & Development, University of Delaware Clinical Trials Management Certificate
  • Clinical Contracting Efficiency and Clinical Trials: A Simple but Overlooked Means to Save Millions, Applied Clinical Trials (ACT)
  • Deriving Maximum Value from an Overhead Function: The Role of the Legal Department in Clinical Development, North Carolina Regulatory Affairs Forum (NCRAF)
  • Maximizing Efficiency When Working with CROs, ACT
  • CRO-Sponsor Agreements: Compliance Traps for the Unwary, Model Agreements & Guidelines International (MAGI)
  • Clinical Trial Agreements Outside the U.S.: International Considerations When Contracting Abroad, MAGI
  • Acquisition of marketed pharmaceutical product and of marketed medical device
  • License and supply agreement for manufacture and sale of diagnostic product in India
  • Exclusive in-license of biologic product from Japanese company
  • All contracts and legal issues related to R&D programs for Humira®, the #1 selling drug in the world
  • License agreements with University of Florida, Duke University, University of North Carolina, University of Virginia and Virginia Tech
  • $2.6M bridge financing for early-stage pharmaceutical company

Sign Up For Updates